{
  "id": 5439,
  "text": "Cancer Chemother Pharmacol 1986;18:280-283.Available at: http://www.ncbi.nlm.nih.gov/pubmed/3802384.258.Sutton GP, Blessing JA, McGuire WP, et al.Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Cancer Chemother Pharmacol 1986;18:280-283.Available at: http://www.ncbi.nlm.nih.gov/pubmed/3802384.258.Sutton GP, Blessing JA, McGuire WP, et al.Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "这项研究的药物试验是针对从未接受过化疗的晚期或复发性鳞状细胞宫颈癌患者进行的。",
  "query": "这项研究是针对哪些类型的患者进行的药物试验？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这项研究是针对哪些类型的患者进行的药物试验？\n\n<reference text>: Cancer Chemother Pharmacol 1986;18:280-283.Available at: http://www.ncbi.nlm.nih.gov/pubmed/3802384.258.Sutton GP, Blessing JA, McGuire WP, et al.Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "这项研究的药物试验是针对从未接受过化疗的晚期或复发性鳞状细胞宫颈癌患者进行的。"
}